Artemis Medicare FY26 Profit Hits ₹103 Cr, Board Proposes 45% Dividend

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Artemis Medicare FY26 Profit Hits ₹103 Cr, Board Proposes 45% Dividend
Overview

Artemis Medicare Services Ltd. announced its audited financial results for the fiscal year ending March 31, 2026, reporting a net profit of ₹103.72 crore on revenues of ₹1,081.24 crore. The Board recommended a final dividend of Re. 0.45 per equity share and announced the appointment of two new independent directors, alongside re-appointing statutory auditors for five years.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Artemis Medicare FY26: Financials, Dividend, and Governance Updates

Financial Performance in Focus
Artemis Medicare Services Ltd. has released its audited financial results for the fiscal year ending March 31, 2026. The company reported consolidated revenue of ₹1,081.24 crore and a net profit after tax of ₹103.72 crore. Standalone figures showed revenue at ₹1,060.49 crore with a net profit of ₹103.44 crore.

Dividend Recommendation
The company's Board of Directors has recommended a final dividend of Re. 0.45 per equity share. This distribution represents 45% of the face value for the fiscal year 2026, offering a direct return to shareholders.

Governance and Appointments
In terms of corporate governance, Artemis Medicare is set to strengthen its board with the addition of two independent directors. Mr. Tapan Mitra has been appointed as an Additional Independent Director, while shareholder approval is pending for Dr. Girdhar J. Gyani's appointment as an Independent Director. Furthermore, M/s. T R Chadha & Co LLP has been re-appointed as the Statutory Auditors for a five-year term, ensuring continuity in financial oversight.

Operational Context and Peer Comparison
Artemis Medicare operates a network of multi-specialty hospitals, primarily serving North India. Its FY26 revenue of approximately ₹1,081 crore places it smaller in scale compared to major healthcare groups. For instance, Apollo Hospitals reported FY24 revenue of ₹15,074 crore, Fortis Healthcare ₹6,888 crore, and Max Healthcare ₹5,555 crore. Despite the difference in scale, Artemis Medicare's reported profit margin appears competitive, indicating efficient operations within its market segment.

Investor Watchlist
Key actions for investors to monitor include the upcoming Annual General Meeting (AGM) where shareholder voting will confirm the new director appointments. The timely declaration and payment of the recommended dividend are also points of interest. Investors will likely look for management's commentary on future growth strategies and performance expectations for the current fiscal year, FY27.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.